Zhang HD, Ding L, Liu K, Mi LJ, Zhang AK, Yu FY, et al
22 Variations in formulation, dosing schedules, and dual agonism with tirzepatide influence tolerability, emphasizing the need for individualized therapy
Final thoughts If youre reading this because youre considering GLP-1 therapy, or already using it and want a more comprehensive approach, here are key take-aways: GLP-1s can be powerful tools for glycemic control and weight/metabolic healthbut they carry side-effects and nutrient risks
A telehealth provider will screen for these during the intake process
We need further research to understand the full potential of GLP-1 RAs and all the intricacies of their MOA for optimal clinical use